Hemostatic effects of recombinant DisBa-01, a disintegrin from Bothrops alternatus

Frontiers in Bioscience

Volumn 13, Issue 17, 2008, Pages 6604-6616

  Kauskot, Alexandre ^a,b   Cominetti, Marcia R ^c   Ramos, Oscar H P ^c   Bechyne, Iga ^a,b   Renard, Jean Marie ^a,b   Hoylaerts, Marc F ^d   Crepin, Michel ^e   Legrand, Chantal ^a,b   Selistre De Araujo, Heloisa S ^c   Bonnefoy, Arnaud ^f,g  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITÉ PARIS 13   (France)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Beta3 Integrin; Bleeding Time; Bothrops alternatus; Dynamic Conditions; Focal Adhesion Kinase; Phosphorylation; Platelet aggregation; RGD disintegrin; Thrombosis

Indexed keywords

BOTHROPS; BOTHROPS ALTERNATUS; CRICETULUS GRISEUS; MURINAE; MUS; ORYCTOLAGUS CUNICULUS;

FOCAL ADHESION KINASE 1; HEMOSTATIC AGENT; PTK2 PROTEIN, HUMAN; RECOMBINANT PROTEIN; SNAKE VENOM;

ANIMAL; ARTICLE; CHO CELL; CRICETULUS; DRUG EFFECT; GENETIC TRANSFECTION; HAMSTER; HEMOSTASIS; HUMAN; METABOLISM; PHOSPHORYLATION; SNAKE; THROMBOCYTE ADHESIVENESS; THROMBOCYTE AGGREGATION;

ANIMALS; BOTHROPS; CHO CELLS; CRICETINAE; CRICETULUS; CROTALID VENOMS; FOCAL ADHESION KINASE 1; HEMOSTASIS; HEMOSTATICS; HUMANS; PHOSPHORYLATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 52049108900     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bauab F.A., G.R. Junqueira, M.C. Corradini, P.V. Silveira & A. Nishioka Sde: Clinical and epidemiological aspects of the 'urutu' lance-headed viper (Bothrops alternatus) bite in a Brazilian hospital. Trop Med Parasitol 45, 243-245 (1994) (Pubitemid 24312033)
2. Nisenbom H.E., J.C. Perazzo, A.J. Monserrat & J.C. Vidal: Contribution of phospholipase A2 to the lethal potency of Bothrops alternatus (vibora de la cruz) venom. Toxicon 24, 807-817 (1986)
3. Smolka M.B., S. Marangoni, B. Oliveira, & J.C. Novello: Purification and partial characterization of a thrombin-like enzyme, balterobin, from the venom of Bothrops alternatus. Toxicon 36, 1059-1063 (1998) (Pubitemid 28305399)
4. Castro H.C., D.L. Dutra, A.L. Oliveira-Carvalho, & R.B. Zingali: Bothroalternin, a thrombin inhibitor from the venom of Bothrops alternatus. Toxicon 36, 1903-1912 (1998) (Pubitemid 28532768)
5. Souza D.H., M.R. Iemma, L.L. Ferreira, J.P. Faria, M.L. Oliva, R.B. Zingali, S. Niewiarowski & H.S. Selistre-de- Araujo: The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2beta1 integrinmediated cell adhesion. Arch Biochem Biophys 384, 341-350 (2000) (Pubitemid 32012809)
6. Gould R.J., M.A. Polokoff, P.A. Friedman, T.F. Huang, J.C. Holt, J.J. Cook & S. Niewiarowski: Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 195, 168-171 (1990) (Pubitemid 20373198)
7. Calvete J.J., M.P. Moreno-Murciano, R.D. Theakston, D.G. Kisiel & C. Marcinkiewicz: Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem J 372, 725-734 (2003) (Pubitemid 36760386)
8. Fox, J.W., & S.M.T. Serrano: Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 45, 969-985 (2005) (Pubitemid 40732574)
9. McLane M.A., E.E. Sanchez, A. Wong, C. Paquette- Straub & J.C. Perez: Disintegrins. Curr Drug Targets Cardiovasc Haematol Disord 4, 327-355 (2004) (Pubitemid 39562089)
10. Sloan E.K., N. Pouliot, K.L. Stanley, J. Chia, J.M. Moseley, D.K. Hards & R.L. Anderson: Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res 8, 1-14 (2006)
11. Sheu, J.R., M.H. Yen, Y.C. Kan, W.C. Hung, P.T. Chang & H.N. Luk: Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody. Biochim Biophys Acta 1336, 445-454 (1997)
12. Swenson S., F. Costa, R. Minea, R.P. Sherwin, W. Ernst, G. Fujii, Y. Yang, F.S. Markland: Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther 3, 499-511 (2004) (Pubitemid 39193728)
13. Zhao, Y., R. Bachelier, I. Treilleux, P. Pujuguet, O. Peyruchaud, R. Baron, P. Clement-Lacroix, P. Clezardin: Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res 67, 5821-5830 (2007) (Pubitemid 46985016)
14. Gomes N., J. Vassy, C. Lebos, B. Arbeille, C. Legrand & F. Fauvel-Lafeve: Breast carcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists. Clin Exp Metast 21, 553-561 (2004)
15. Gupta G.P., & J. Massague: Platelets and metastasis revisited: a novel fatty link. J Clin Invest 114, 1691-1693 (2004) (Pubitemid 40385522)
16. Nieswandt B., M. Hafner, B. Echtenacher & D.N. Mannel: Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59, 1295-1300 (1999) (Pubitemid 29136261)
17. Karpatkin S. & E. Pearlstein: Role of platelets in tumor cell metastases. Ann Intern Med 95, 636-641 (1981) (Pubitemid 12231807)
18. Trikha M & M.T. Nakada: Platelets and cancer: implications for antiangiogenic therapy. Sem Thromb Hemost 28, 39-44 (2002) (Pubitemid 34194871)
19. Ramos O.H., A. Kauskot, M.R. Cominetti, I. Bechyne, C.L. Salla Pontes, F. Chareyre, J. Manent, R. Vassy, M. Giovannini, C. Legrand, H.S. Selistre-de-Araujo, M. Crepin & A. Bonnefoy. A novel alpha(v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis. Clin Exp Metastasis (2007)
20. Xia Z., T. Wong, Q. Liu, A. Kasirer-Friede, E. Brown & M.M. Frojmovic: Optimally functional fluorescein isothiocyanate-labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation. Br J Haematol 93, 204-214 (1996) (Pubitemid 26132397)
21. Alig L., A. Edenhofer, P. Hadvary, M. Hürzeler, D. Knopp, M. Muller, B. Steiner, A. Trzeciak & T. Weller: Low molecular weight, non-peptide fibrinogen receptor antagonists. J Med Chem 35, 4393-4407 (1992)
22. Jacome D., M.M. Melo, M.M. Santos & L.G. Heneine: Kinetics of venom and antivenom serum and clinical parameters and treatment efficacy in Bothrops alternatus envenomed dogs. Vet Hum Toxicol 44, 334-338 (2002) (Pubitemid 35334836)
23. Hantgan R.R., M.C. Stahle, J.H. Connor, R.F. Connor & S.A. Mousa: AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists. J Thromb Haemost 5, 542-550 (2007) (Pubitemid 46680688)
24. Belisario M.A, S. Tafuri, C. Di Domenico, R. Della Morte, C. Squillacioti, A. Lucisano & N. Staiano: Immobilised echistatin promotes platelet adhesion and protein tyrosine phosphorylation. Biochim Biophys Acta 1497, 227-236 (2000) (Pubitemid 30618834)
25. Jirouskova M., J.K. Jaiswal & B.S. Coller: Ligand density dramatically affects integrin alphaIIbbeta3- mediated platelet signaling and spreading. Blood 109, 5260-5269 (2007) (Pubitemid 46890546)
26. Artoni A., J. Li , B. Mitchell, J. Ruan, J. Takagi, T.A. Springer, D.L. French & B.S. Coller: Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation. Proc Natl Acad Sci USA. 101, 13114-13120 (2004) (Pubitemid 39209628)
27. Coller B.S., J.D. Folts, S.R. Smith, L.E. Scudder & R. Jordan: Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors. Circulation 80, 1766-1774 (1989) (Pubitemid 20031708)
28. Tam S.H., P.M. Sassoli, R.E. Jordan & M.T. Nakada: Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins. Circulation 98, 1085-1091 (1998) (Pubitemid 28420700)
29. D'Souza S.E., T.A. Haas, R.S. Piotrowicz, V. Byers- Ward, D.E. McGrath, H.R. Soule, C. Cierniewski, E.F. Plow & J.W. Smith: Ligand and cation binding are dual functions of a discrete segment of the integrin beta 3 subunit: cation displacement is involved in ligand binding. Cell 79, 659-667 (1994) (Pubitemid 24363809)
30. Coller, B.S: Anti-GPIIb/IIIa drugs: current strategies and future directions. Thromb Haemost 86, 427-443 (2001) (Pubitemid 32663972)
31. Frojmovic, M., B. Labarthe & C. Legrand: Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban. Br J Haematol 131, 348-355 (2005) (Pubitemid 43899667)
32. Hu, D.D. C.A. White, S. Panzer-Knodle, J.D. Page, N. Nicholson, & J.W. Smith: A new model of dual interacting ligand binding sites on integrin alphaIIbbeta3. J Biol Chem 274, 4633-4639 (1999)
33. Shattil S.J., H. Kashiwagi, N. Pampori: Integrin signaling: the platelet paradigm. Blood 91, 2645-2657 (1998) (Pubitemid 28227512)
34. Schaller M.D., C.A. Borgman & J.T. Parsons: Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol Cell Biol 13, 785-791 (1993) (Pubitemid 23040243)
35. Lipfert L., B. Haimovich, M.D. Schaller, B.S. Cobb, J.T. Parsons & J.S. Brugge: Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol 119, 905-912 (1992)
36. Haimovich B., L. Lipfert, J.S. Brugge & S.J. Shattil: Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J Biol Chem 268, 15868-15877 (1993) (Pubitemid 23222091)
37. Bianchi M., S. de Lucchini, O. Marin, D. L. Turner, S. K. Hanks & E. Villa-moruzzi: Biochem J. 391, 359-370 (2005)
38. Calvete, J.J., M.A. McLane, G.J. Stewart, & S. Niewiarowski: Characterization of the cross-linking site of disintegrins albolabrin, bitistatin, echistatin, and eristostatin on isolated human platelet integrin GPIIb/IIIa. Biochem Biophys Res Commun 202, 135-140 (1994) (Pubitemid 24252575)
39. Staiano N., R. Della Morte, C. Di Domenico, S. Tafuri, C. Squillacioti, M.A. Belisario & P. Di Natale: Echistatin inhibits pp72syk and pp125FAK phosphorylation in fibrinogen-adherent platelets. Biochimie 79, 769-773 (1997) (Pubitemid 28073483)
40. Clark, E.A., M. Trikha, F.S. Markland, & J.S. Brugge: Structurally distinct disintegrins contortrostatin and multisquamatin differentially regulate platelet tyrosine phosphorylation. J Biol Chem 269, 21940-21943 (1994) (Pubitemid 24282110)